admin

DRAP has issued a rapid alert against falsified drug products, with spurious batches seized. PPMA supports this action to safeguard public health and ensure safe, quality medicines for all.

With evolving US tariffs, Pakistan’s pharmaceutical industry is well-positioned to capture larger market share, reinforcing its reputation for quality and affordability.

𝐏𝐚𝐤𝐢𝐬𝐭𝐚𝐧 𝐚𝐧𝐝 𝐂𝐡𝐢𝐧𝐚 unite to build an advanced antibiotic plant driving innovation, boosting healthcare, and shaping a healthier tomorrow.As proud members of PPMA, Citi Pharma’s milestone reflects the collective strength of Pakistan’s pharmaceutical industry in advancing global healthcare.

Pakistan’s pharmaceutical industry is making waves internationally, fueled by its high-quality manufacturing and a significant rise in exports. With growing interest from global companies, the sector is stepping confidently beyond borders and onto the world stage — a true testament to our industry’s dedication and innovation. Pakistan’s pharma is not just growing — it’s going

Pakistan Pharma continues to expand its global reach through key strategic partnerships that benefit both local industry and international markets. In a progressive move to deepen international collaboration, the Pakistan Pharmaceutical Manufacturer Association (PPMA) welcomed the establishment of the Pakistan–UK Business Advisory Council. This forum is set to enhance bilateral trade in pharmaceuticals and healthcare,

PPMA Leadership, led by key executive members, held a productive meeting with DRAP Additional Director Dr. Obaid Ali to discuss regulatory reforms, industry challenges, and future collaboration to uplift Pakistan’s pharmaceutical sector. This strategic meeting marks a significant development in the ongoing efforts to strengthen regulatory coordination in the pharma industry of Pakistan. With the

PPMA appreciates the Finance Minister’s recognition and remains committed to strengthening public–private partnerships for a healthier, self-reliant Pakistan.